NCT00769574

Brief Summary

To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
143

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 9, 2008

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

August 29, 2014

Status Verified

August 1, 2014

Enrollment Period

3.2 years

First QC Date

October 8, 2008

Last Update Submit

August 28, 2014

Conditions

Coronary Syndrome

Outcome Measures

Primary Outcomes (1)

  • To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

    24 months

Secondary Outcomes (1)

  • Compare the characteristics of biological markers to those of usual or innovative markers

    24 months

Study Arms (2)

1

EXPERIMENTAL

Patients with coronary syndrome

Other: Biological analysis of biomarkers

2

OTHER

Subjects without coronary syndrome

Other: Biological analysis of biomarkers

Interventions

Biological analysis of biomarkersOTHER

Biological analysis of biomarkers

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subjects over 18 years,
  • subject about having a chest pain of coronary syndrome,
  • subject about not having received heparin or LMWH

You may not qualify if:

  • subject minor
  • subject without informed consent,
  • subject after receiving an anticoagulant treatment,
  • transplanted heart, kidney or liver

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital de la Timone- Service cardiologie A

Marseille, 13385, France

Location

MeSH Terms

Conditions

Angina, Unstable

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jean-Louis BONNET, MD

    Assistance Publique des Hôpitaux de Marseille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2008

First Posted

October 9, 2008

Study Start

June 1, 2008

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

August 29, 2014

Record last verified: 2014-08

Locations

FR(1)